R

Retina Northwest, PC | Portland, OR

Research site

(Unclaimed)

Location

54450 SW Westgate Drive, Suite 217, Portland, Oregon, United States of America

Site insights

Top conditions

Top treatments

Bevacizumab

-Ranibizumab

Ranibizumab

APL-2

Triamcinolone Acetonide

ranibizumab

NSAID

zeaxanthin

Zimura

MK-8748

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 28 total trials

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) (MALBEC)

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).Available standard (usual) treatments for NVAMD, s...

Enrolling

Choroidal Neovascularization

Age-Related Macular Degeneration

Drug: Tiespectus

Drug: Aflibercept

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD (ATMOSPHERE)

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Active, not recruiting

Choroidal Neovascularization

Wet Age-related Macular Degeneration

Genetic: ABBV-RGX-314

Biological: Ranibizumab (LUCENTIS®)

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

The goal of this clinical trial is to evaluate the efficacy, safety and pharmacokinetics of elamipretide in subjects with dry age-related macular deg...

Active, not recruiting

Age Related Macular Degeneration (ARMD)

Drug: Elamipretide

Drug: Placebo